(News Bulletin 247) – Carmat rose on the stock market on Thursday after declaring itself confident in its ability to extend its financing horizon beyond July 2023, despite an environment described as ‘difficult’.
The manufacturer of artificial hearts announced this morning that its cash position stood at 51.4 million euros at December 31, 2022, an increase of 12.2 million euros compared to the end of 2021.
In its press release, the group indicates that it is “actively” exploring different options in order to secure the financing necessary for the continuation of its activities beyond July 2023, saying that it is confident in its ability to find the resources necessary for its development.
Regarding the 2022 financial year, Carmat recalls having achieved its main objective, namely the resumption of the installation of its artificial Aeson.
Its annual turnover reached 0.3 million euros, a figure which corresponds to the sale of two artificial hearts due to the resumption of implantations last November.
Its operating loss was contained at 51.9 million euros in 2022 thanks to cost control, compared with a loss of 60.4 million euros in 2021.
The group has also confirmed its financial objectives, starting with achieving a turnover of 10 to 13 million euros in 2023.
Around 9:45 a.m., the Carmat title rose by 2.2% in a Parisian market up by 0.4%.
Copyright (c) 2023 News Bulletin 247. All rights reserved.
I have over 8 years of experience working in the news industry. I have worked as a reporter, editor, and now managing editor at 247 News Agency. I am responsible for the day-to-day operations of the news website and overseeing all of the content that is published. I also write a column for the website, covering mostly market news.
